Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Normal
[URL unfurl="true"]https://www.excelmale.com/forum/threads/temporary-implantable-nitinol-device-in-men-with-luts-secondary-to-bph.21897/#post-188352[/URL]ConclusionTreatment of BPO-related LUTS with the second-generation temporary implantable nitinol device demonstrated a significant and durable reduction in symptoms and improvement in functional parameters and quality of life at 3 years of follow-up. As for the first-generation device, no late postoperative complications were observed between 12 and 36 months. No impact on ejaculatory function and a low, total, and cumulative (8.6%) treatment failure rate from baseline to 3 years was recorded.
[URL unfurl="true"]https://www.excelmale.com/forum/threads/temporary-implantable-nitinol-device-in-men-with-luts-secondary-to-bph.21897/#post-188352[/URL]
Conclusion
Treatment of BPO-related LUTS with the second-generation temporary implantable nitinol device demonstrated a significant and durable reduction in symptoms and improvement in functional parameters and quality of life at 3 years of follow-up. As for the first-generation device, no late postoperative complications were observed between 12 and 36 months. No impact on ejaculatory function and a low, total, and cumulative (8.6%) treatment failure rate from baseline to 3 years was recorded.
We use essential cookies to make this site work, and optional cookies to enhance your experience.
See further information and configure your preferences
